For too long, women with bleeding disorders have been denied the care that they need, writes columnist Jennifer Lynne.

Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

While blood clots serve an essential purpose in healing injuries, they can transform into life-threatening conditions when ...

Blood thinners prescribed after blood clots in leg or lung initially increase the risk of bleeding, especially in women and ...

Bleeding disorders refer to a group of conditions characterized by difficulties in blood clotting, leading to prolonged bleeding or excessive bruising. These disorders can be congenital (inherited ...

UC San Diego Health is one of a few health care systems on the West Coast to offer a new gene therapy for hemophilia B, a bleeding disorder that prevents blood from clotting properly. The FDA ...

The introduction of specialized clotting factors and advanced blood products has revolutionized treatment, particularly for patients with bleeding disorders. These innovations have dramatically ...

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

[1–2] Failure of these regulatory pathways could result in either abnormal clot formation or excessive bleeding ... Individualized healthcare in clotting disorders has been, and will continue ...

Abnormal uterine (womb) bleeding is a common problem in women. Abnormal uterine bleeding can occur as either a change in your normal menstrual period or as bleeding in between your normal menses.

Explore the genetic findings in 527 rare bleeding disorder cases, presented at EAHAD 2024, shedding light on novel variants.

The National Hemophilia Foundation (hemophilia.org) is dedicated to raising awareness of hemophilia and to finding cures and better treatments for bleeding and clotting disorders. Hemophilia is an ...